Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1991
12/26/1991WO1991019743A2 COMBINED TREATMENT WITH GnRH ANTAGONIST AND GnRH TO CONTROL GONADOTROPIN LEVELS IN MAMMALS
12/26/1991WO1991019741A1 Albumin binding proteins
12/26/1991WO1991019740A1 IgG-BINDING PROTEIN
12/26/1991WO1991019734A2 Thrombin inhibitors based on the amino acid sequence of hirudin
12/26/1991WO1991019733A1 Derivatives of tetrapeptides as cck agonists
12/26/1991WO1991019515A1 Oligomeric immunoglobulin constant domain mutant with enhanced complement-mediated cytolytic activity
12/26/1991WO1991019514A1 An anticoagulant preparation
12/26/1991WO1991019513A1 METHODS OF MODULATING BLOOD PRESSURE USING TGF-β AND ANTAGONISTS THEREOF
12/26/1991WO1991019512A1 Antimicrobial peptides
12/26/1991WO1991019511A1 CONTROLLING CELLULAR IMMUNE/INFLAMMATORY RESPONSES WITH β2 INTEGRINS
12/26/1991WO1991019510A1 Osteoinductive pharmaceutical formulations
12/26/1991WO1991019509A1 Protein a and polypeptide of its molecule for the treatment of tumors
12/26/1991WO1991019508A1 Nerve-regenerating agent
12/26/1991WO1991019505A1 Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin
12/26/1991WO1991019501A1 Intercellular adhesion mediators
12/26/1991WO1991019482A1 Aminosteroids for ophthalmic use
12/26/1991WO1991017773A3 New protein-polycation conjugates
12/26/1991CA2085980A1 Protease nexin-i variants
12/26/1991CA2085101A1 An anticoagulant preparation
12/26/1991CA2084992A1 Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof
12/26/1991CA2045294A1 Agent for therapy
12/25/1991CN1057295A Process for isolation and expression of human ciliary neuronotrophic factor by recombinant dna technology
12/25/1991CN1057294A Method for recombinant production of hirudins
12/25/1991CN1057268A Crystalline interleukin-4
12/24/1991US5075431 Chimeric anti-CEA antibody
12/24/1991US5075425 Process for the preparation of a pharmaceutical which contains igg, iga and igm and can be administered intravenously
12/24/1991US5075424 Acidification of milk solution, ultrafiltration
12/24/1991US5075423 Purification of protein a by affinity chromatography followed by anion exchange
12/24/1991US5075302 Treating hypertension, congestive heart failure
12/24/1991US5075288 Sleep inducer
12/24/1991US5075287 Enhance activity of vaccines, bactericides, antitumor agents
12/24/1991US5075231 Lipases and lipase extracts, their preparation process and their therapeutic use
12/24/1991US5075230 Stabilized plasminogen activator precursor and method of producing the same
12/24/1991US5075228 Hydrib conposed of chlamydia and escherichia components
12/24/1991US5075224 Prepro-LHRH C-terminal peptide DNA
12/24/1991US5075222 Dna sequences
12/24/1991US5075211 Complexing antibodies with oligopeptides, blood screening
12/24/1991US5075109 Administering in encapsulated form
12/24/1991CA1293591C Peptide substrates for detecting virus-specified protease activity
12/24/1991CA1293589C Carboxyalkyl amino acid derivatives of various substituted prolines
12/24/1991CA1293444C Amino acid chelated compositions for delivery to specific biologicaltissue sites
12/24/1991CA1293443C Controlled release of macromolecular polypetides
12/23/1991WO1992000100A1 Improved ascites production of monoclonal antibodies using an immunosuppressive anti-cd4-related antibody
12/23/1991CA2085586A1 Ascites production of monoclonal antibodies using an immunosuppressive anti-cd4-related antibody
12/22/1991CA2045071A1 Acellular anti-pertussis vaccines
12/22/1991CA2044858A1 Method of treating bladder cancer cells
12/22/1991CA2043992A1 Use of cytokine-containing aerosols and the cytokine-containing aerosols
12/21/1991WO1991019798A1 Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof
12/21/1991CA2084659A1 Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof
12/21/1991CA2044979A1 Coated veterinary implants
12/20/1991WO1991019480A1 Pharmaceutical preparation
12/20/1991CA2085100A1 Pharmaceutical preparation
12/19/1991WO1991019736A2 Cancer-associated scm-recognition factor, preparation and method of use
12/19/1991CA2084767A1 Cancer-associated scm-recognition factor, preparation and method of use
12/19/1991CA2044741A1 Hiv gp120 monoclonal antibodies
12/19/1991CA2044736A1 Peptides derivatives, their preparation process and pharmaceutical compositions containing them
12/18/1991EP0462071A1 Pharmaceutical resorption-improved somatostatin compositions, their preparation and use
12/18/1991EP0461869A2 Chemotherapeutic agents
12/18/1991EP0461799A2 Bacillus thuringiensis isolate having anti-protozoan activity
12/18/1991EP0461707A2 Peptide oxytocin antagonists
12/18/1991EP0461696A1 Crystalline polypeptides with corticotropic activity
12/18/1991EP0461560A1 Recombinant human hepatocyte growth factor and method for production thereof
12/18/1991EP0461548A2 Method for preventing a second heart attack employing and HMG CoA reductase inhibitor
12/18/1991EP0461546A2 Antiherpes peptide derivatives having a 1,4-dioxo-C4 N-terminus
12/18/1991EP0461530A2 Synergistic antimicrobial compositions
12/18/1991EP0461330A1 Protease inhibitory fraction
12/18/1991EP0461261A1 Oligopeptide mixture and composition containing the same
12/18/1991EP0461245A1 Radiolabeled proteins for diagnostic or therapeutic use
12/18/1991EP0461177A1 Human intra-acrosomal sperm antigen for use in a contraceptive vaccine
12/18/1991EP0461159A1 Il-2 analogs containing n-linked glycosylation sites
12/18/1991EP0455741A4 Method for detecting inhibitors of tat protein
12/18/1991EP0289572B1 Anti-arthritic use of interleukin-1 proteins
12/18/1991EP0108128B1 (met-1,des-cys1,des-tyr2,des-cys3) human gamma interferon and a dna sequence encoding it
12/18/1991CN1057072A Monoclonal anti-igm antibodies, their production and use, and hybridomas for producing same
12/17/1991US5073630 Culture product, phosphate anhydride
12/17/1991US5073627 Animal growth regulator
12/17/1991US5073624 Therapeutic decapeptides
12/17/1991US5073549 Antiamnesia, antidementia
12/17/1991US5073547 Dopamine pro-drug
12/17/1991US5073543 Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
12/17/1991US5073542 CPF peptide compositions and their use in inhibiting growth of target cells or a virus
12/17/1991US5073541 Treatment of small cell lung cancer with somatostatin analogs
12/17/1991US5073540 Composite binding site drugs
12/17/1991US5073539 Transdermal administration of zwitterionic drugs
12/17/1991US5073494 Human tissue plasminogen activator substituted at position 275 or at positions 275 and 277
12/17/1991US5073493 Monoclonal antibody nky13
12/17/1991US5073492 Mixing culture substrate with vascular endothelial cell growth factor, uridine, thymidine and serum-derived factor
12/17/1991US5073378 Freeze drying a centrifuged solution from incubating a mixture with platelet growth factors plasma
12/17/1991US5073374 Drug delivery with active material, water soluble excipient an d lubricant
12/17/1991CA1293214C Process for the preparation of a factor v concentrate
12/17/1991CA1293211C Human tissue plasminogen activator
12/16/1991WO1991019742A1 Crystalline interleukin-4
12/16/1991WO1991019502A1 Intercellular adhesion mediators
12/16/1991CA2085377A1 Crystalline interleukin-4
12/16/1991CA2084888A1 Intercellular adhesion mediators
12/16/1991CA2044511A1 Pharmaceutical resorption-improved somatostatin compositions, their preparation and use
12/15/1991WO1991019793A2 Hybrid plasminogen activators
12/15/1991WO1991019735A1 Libraries of modified peptides with protease resistance
12/15/1991CA2085224A1 Hybrid plasminogen activators
12/15/1991CA2085118A1 Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such
1 ... 2989 2990 2991 2992 2993 2994 2995 2996 2997 2998 2999 3000 3001 3002 3003 3004 3005 3006 3007 3008 3009 ... 3163